Healthcare -
Biotechnology - NASDAQ - US
$ 4.975
-2.26 %
$ 216 M
Market Cap
-2.43
P/E
ABEO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ABEO - Abeona Therapeutics Inc.
208 K
LAST VALUE
-94.39%
2 YEAR CAGR
14.90%
5 YEAR CAGR
59.42%
10 YEAR CAGR